265 related articles for article (PubMed ID: 33332077)
1. Dexmedetomidine alleviates pulmonary ischemia-reperfusion injury through modulating the miR-21-5p/Nr4a1 signaling pathway.
Dong W; Yang H; Cheng M; Zhang X; Yin J; Zeng Z; Huang G
Acta Biochim Pol; 2020 Dec; 67(4):521-529. PubMed ID: 33332077
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Alleviates Brain Ischemia/Reperfusion Injury by Regulating Metastasis-associated Lung Adenocarcinoma Transcript 1/MicroRNA-140-5p/ Nuclear Factor Erythroid-derived 2-like 2 Axis.
Qin Z; Xu Y
Protein Pept Lett; 2024; 31(2):116-127. PubMed ID: 38083898
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α
Li J; Chen Q; He X; Alam A; Ning J; Yi B; Lu K; Gu J
J Transl Med; 2018 Mar; 16(1):78. PubMed ID: 29566706
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine inhibits inflammatory response and oxidative stress through regulating miR-205-5p by targeting HMGB1 in cerebral ischemic/reperfusion.
Yang JJ; Zhao YH; Yin KW; Zhang XQ; Liu J
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):478-486. PubMed ID: 34196265
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study.
Chen L; Cao J; Cao D; Wang M; Xiang H; Yang Y; Ying T; Cong H
Life Sci; 2019 Oct; 235():116553. PubMed ID: 31185237
[TBL] [Abstract][Full Text] [Related]
9. Circ_0057583 facilitates brain microvascular endothelial cell injury through modulating miR-204-5p/NR4A1 axis.
Wang X; Liu L; Zhang L; Guo J; Yu L; Li T
Metab Brain Dis; 2022 Feb; 37(2):501-511. PubMed ID: 34767155
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA cerebellar degeneration-related protein 1 antisense RNA (Circ-CDR1as) downregulation induced by dexmedetomidine treatment protects hippocampal neurons against hypoxia/reoxygenation injury through the microRNA-28-3p (miR-28-3p)/tumor necrosis factor receptor-associated factor-3 (TRAF3) axis.
Wang J; Wang Y
Bioengineered; 2021 Dec; 12(2):10512-10524. PubMed ID: 34787053
[TBL] [Abstract][Full Text] [Related]
11. Up-regulating microRNA-138-5p enhances the protective role of dexmedetomidine on myocardial ischemia-reperfusion injury mice via down-regulating Ltb4r1.
Chang Y; Xing L; Zhou W; Zhang W
Cell Cycle; 2021 Feb; 20(4):445-458. PubMed ID: 33509010
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
[TBL] [Abstract][Full Text] [Related]
13. MiR-539-5p alleviates sepsis-induced acute lung injury by targeting ROCK1.
Meng L; Cao H; Wan C; Jiang L
Folia Histochem Cytobiol; 2019; 57(4):168-178. PubMed ID: 31825519
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
Zhang Y; Zhao Q; Li X; Ji F
Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine reduces propofol-induced hippocampal neuron injury by modulating the miR-377-5p/Arc pathway.
Chen Z; Ding Y; Zeng Y; Zhang XP; Chen JY
BMC Pharmacol Toxicol; 2022 Mar; 23(1):18. PubMed ID: 35337381
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of dexmedetomidine in a rat ex vivo lung model of ischemia-reperfusion injury.
Zhou Y; Zhou X; Zhou W; Pang Q; Wang Z
Acta Cir Bras; 2018 Jan; 33(1):1-13. PubMed ID: 29412228
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA-327 ameliorates ischemia/reperfusion injury-induced cardiomyocytes apoptosis through targeting apoptosis repressor with caspase recruitment domain.
Li Q; Yang J; Zhang J; Liu XW; Yang CJ; Fan ZX; Wang HB; Yang Y; Zheng T; Yang J
J Cell Physiol; 2020 Apr; 235(4):3753-3767. PubMed ID: 31587299
[TBL] [Abstract][Full Text] [Related]
18. [Dexmedetomidine alleviates hepatic ischemia-reperfusion injury by regulating MALAT1/miR-126-5p/HMGB1 axis].
Ma XG; Liu Y; Xue MX
Sheng Li Xue Bao; 2021 Apr; 73(2):253-262. PubMed ID: 33903887
[TBL] [Abstract][Full Text] [Related]
19. NR4A1 silencing protects against renal ischemia-reperfusion injury through activation of the β-catenin signaling pathway in old mice.
Shi W; Dong J; Liang Y; Liu K; Peng Y
Exp Mol Pathol; 2019 Dec; 111():104303. PubMed ID: 31465766
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway.
Liang S; Wang Y; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):370-377. PubMed ID: 30657579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
